{"count":8,"next":null,"previous":null,"results":[{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments","publications":[],"evidence":["Expert Review Green","Expert list"],"phenotypes":["Renal cancer"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":154,"hash_id":"596f8d5c8f620352d1224c2a","name":"Renal cancer pertinent cancer susceptibility","disease_group":"Cancer Programme","disease_sub_group":"Pertinent cancer susceptibility gene panel","status":"public","version":"1.1","version_created":"2019-06-20T15:14:12.998750Z","relevant_disorders":["Renal"],"stats":{"number_of_genes":10,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Cancer Germline 100K","slug":"cancer-germline-100k","description":"Cancer Germline 100K"}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":null,"publications":[],"evidence":["Expert list","Expert Review Green"],"phenotypes":["Renal cell cancer, papillary carcinoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":391,"hash_id":null,"name":"Adult solid tumours for rare disease","disease_group":"Tumour syndromes","disease_sub_group":"Tumour syndromes","status":"public","version":"1.22","version_created":"2019-06-20T15:10:02.142139Z","relevant_disorders":["Young adult onset cancer","Exceptionally young adult onset cancer","Multiple Tumours","Rare tumour predisposition syndromes"],"stats":{"number_of_genes":58,"number_of_strs":0,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Adult solid tumours for rare disease (Version 1.21)"],"phenotypes":["Renal cell cancer, papillary carcinoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":470,"hash_id":null,"name":"Tumour predisposition - adult onset","disease_group":"","disease_sub_group":"","status":"public","version":"1.1","version_created":"2019-06-20T15:14:23.703488Z","relevant_disorders":[],"stats":{"number_of_genes":63,"number_of_strs":0,"number_of_regions":2},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"3","penetrance":"Incomplete","mode_of_pathogenicity":null,"publications":["PMID: 27899189"],"evidence":["Expert Review Green","Expert List","UKGTN"],"phenotypes":["hereditary papillary renal carcinoma with type 1 papillary tumors"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":521,"hash_id":null,"name":"Inherited renal cancer","disease_group":"","disease_sub_group":"","status":"public","version":"0.40","version_created":"2019-09-24T13:59:02.212399Z","relevant_disorders":["R224"],"stats":{"number_of_genes":16,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":"","publications":["20212079","26185613","23042784","24267887","26166478","25989142","24090431","24581740","26167905","23999528","25294932"],"evidence":["Expert Review Amber","SFARI"],"phenotypes":[],"mode_of_inheritance":"","tags":[],"panel":{"id":657,"hash_id":null,"name":"Autism","disease_group":"","disease_sub_group":"","status":"public","version":"0.15","version_created":"2019-06-20T15:10:14.437740Z","relevant_disorders":[],"stats":{"number_of_genes":733,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Research","slug":"research","description":"This is a gene panel used for research."}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments","publications":[],"evidence":["NHS GMS","Expert Review Green","Expert list"],"phenotypes":["Renal cell cancer, papillary carcinoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":245,"hash_id":"595ce30f8f62036352471f39","name":"Adult solid tumours cancer susceptibility","disease_group":"Cancer Programme","disease_sub_group":"Pertinent cancer susceptibility gene panel","status":"public","version":"1.7","version_created":"2019-08-13T09:55:08.772098Z","relevant_disorders":["Carcinoma of unknown primary","Other","Adult solid tumours pertinent cancer susceptibility"],"stats":{"number_of_genes":103,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Cancer Germline 100K","slug":"cancer-germline-100k","description":"Cancer Germline 100K"},{"name":"GMS Cancer Germline Virtual","slug":"gms-cancer-germline-virtual","description":"This is a panel used for WGS germline analysis for the GMS."}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Victorian Clinical Genetics Services"],"phenotypes":[],"mode_of_inheritance":"","tags":[],"panel":{"id":285,"hash_id":"558aa423bb5a16630e15b63c","name":"Intellectual disability","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodevelopmental disorders","status":"public","version":"2.1065","version_created":"2019-10-07T13:42:16.019766Z","relevant_disorders":["Coarse facial features including Coffin-Siris-like disorders","ID","Moderate","severe or profound intellectual disability","Schizophrenia plus additional features","Intellectual disability - microarray","fragile X and sequencing"],"stats":{"number_of_genes":2253,"number_of_strs":11,"number_of_regions":57},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["HGFR","RCCP2","DFNB97"],"biotype":"protein_coding","hgnc_id":"HGNC:7029","gene_name":"MET proto-oncogene, receptor tyrosine kinase","omim_gene":["164860"],"alias_name":["hepatocyte growth factor receptor"],"gene_symbol":"MET","hgnc_symbol":"MET","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"7:116312444-116438440","ensembl_id":"ENSG00000105976"}},"GRch38":{"90":{"location":"7:116672390-116798386","ensembl_id":"ENSG00000105976"}}},"hgnc_date_symbol_changed":"1986-01-01"},"entity_type":"gene","entity_name":"MET","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["18564920"],"evidence":["Expert list"],"phenotypes":[],"mode_of_inheritance":"BOTH monoallelic and biallelic, autosomal or pseudoautosomal","tags":[],"panel":{"id":65,"hash_id":"57ee82ef8f62035c9b2d0487","name":"Primary lymphoedema","disease_group":"Cardiovascular disorders","disease_sub_group":"Lymphatic Disorders","status":"public","version":"2.0","version_created":"2019-10-02T14:10:33.689992Z","relevant_disorders":["Lymphatic Disorders","Meiges disease","Meige disease","Milroy disease","Lymphoedema distichiasis","Lipoedema disease","R136"],"stats":{"number_of_genes":51,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}}]}